Long-term (48-week) safety of ezetimibe 10 mg/day coadministered with simvastatin compared to simvastatin alone in patients with primary hypercholesterolemia^*

References

• Knopp RH, Gitter H, Truitt T,. et al. Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur Heart J 2003; 24:729–41
   PubMed Web of Science ®Google Scholar
• van Heek M, Farley C, Compton DS,. et al. Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats. Br J Pharmacol 2003; 138:1459-64
   PubMed Web of Science ®Google Scholar
• van Heek M, Compton DS, Davis HR. The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys. Eur J Pharmacol 2001;415: 79-84
   PubMed Web of Science ®Google Scholar
• Ballantyne CM. Role of selective cholesterol absorption inhibition in the management of dyslipidemia. Curr Atheroscler Rep 2004;6:52-9
   PubMedGoogle Scholar
• Sudhop T, Lutjohann D, Kodal A,. et al. Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans. Circulation 2002;106:1943-8
   PubMed Web of Science ®Google Scholar
• Moghadasian M. Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Life Sci 1999;65:1329-37
   PubMed Web of Science ®Google Scholar
• Knopp RH. Drug treatment of lipid disorders. N Engl J Med 1999;341:498-511
   PubMed Web of Science ®Google Scholar
• Stein EA. An investigative look: selective cholesterol absorption inhibitors–embarking on a new standard of care. Am J Managed Care 2002;8:36-9
   Web of Science ®Google Scholar
• Kerzner B, Corbelli J, Sharp S,. et al. Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia. Am J Cardiol 2003;91:418-24
   PubMed Web of Science ®Google Scholar
• Davidson MH, McGarry T, Bettis R,. et al. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia. J Am Coll Cardiol 2002;40:2125-34
   PubMed Web of Science ®Google Scholar
• Ballantyne CM, Houri J, Notarbartolo A,. et al. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Circulation 2003; 107:2409-15
   PubMed Web of Science ®Google Scholar
• Melani L, Mills R, Hassman D,. et al. Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Eur Heart J 2003;24:717-28
   PubMed Web of Science ®Google Scholar
• Shepherd J, Cobbe SM, Ford I,. et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-7
   PubMed Web of Science ®Google Scholar
• Sacks FM, Pfeffer MA, Moye LA,. et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335:1001-9
   Google Scholar
• The Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. Prevention of Cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57
   PubMed Web of Science ®Google Scholar
• Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22
   PubMed Web of Science ®Google Scholar
• Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9
   PubMed Web of Science ®Google Scholar
• Bays H. Statin Safety: An Overview and Assessment of the Data – 2005 [National Lipid Association (NLA) Statin Safety Supplement]. Am J Cardiol 2006;97(Suppl):6-26C
   Web of Science ®Google Scholar
• Masana L, Mata P, Gagne C,. et al. Long-term safety and tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study. Clin Ther 2005;27:174-84
   PubMed Web of Science ®Google Scholar
• Ballantyne CM, Lipka LJ, Sager PT,. et al. Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemia. Int J Clin Pract 2004;58:653-8
   PubMed Web of Science ®Google Scholar
• Ose L, Johnson-Levonas A, Reyes R,. et al. A multi-centre, randomized, double-blind 14 week extension study examining the long-term safety and efficacy profile of the ezetimibe/simvastatin combination tablet. Int J Clin Pract 2007; 61:1469-80
   PubMed Web of Science ®Google Scholar
• Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-23
   Google Scholar
• Goldberg AC, Sapre A, Liu J,. et al. Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 2004;79:620-9
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, , Merz CNB,. et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
   PubMed Web of Science ®Google Scholar
• Bays H. Ezetimibe. Expert Opin Invest Drugs 2002; 11:1587-604
   PubMed Web of Science ®Google Scholar
• Ose L, Bays H, Fraser N,. et al. Efficacy and safety of ezetimibe/simvastatin combination tablet compared with simvastatin alone in patients with primary hypercholesterolemia. Atherosclerosis 2004;5:140-1
   Web of Science ®Google Scholar
• Rossebo A, Pedersen T, Allen C,. et al. Design and baseline characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study. Am J Cardiol 2007;99:970-3
   PubMed Web of Science ®Google Scholar